These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1643820)

  • 61. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
    Trinchieri A; Marchetti F
    Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
    Khajotia RR; Vetter N; Harazin H
    Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of skin and soft tissue infections with oral ciprofloxacin.
    Fass RJ
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():153-7. PubMed ID: 3804903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of i.v. ofloxacin and piperacillin in the treatment of complicated urinary tract infections.
    Schalkhäuser K
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():93-7. PubMed ID: 2286597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia.
    Nichols L; Gudmundsson S; Maki DG
    Rev Infect Dis; 1984; 6 Suppl 3():S711-20. PubMed ID: 6443772
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections.
    Azoicai D; Antoniu SA
    Expert Opin Investig Drugs; 2013 Feb; 22(2):267-76. PubMed ID: 23176385
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Levofloxacin: an updated review of its use in the treatment of bacterial infections.
    Hurst M; Lamb HM; Scott LJ; Figgitt DP
    Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
    Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G
    Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms.
    el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS
    Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy.
    Partsch DJ; Paladino JA
    Ann Pharmacother; 1997 Oct; 31(10):1137-45. PubMed ID: 9337437
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis.
    Senneville E; Yazdanpanah Y; Cazaubiel M; Cordonnier M; Valette M; Beltrand E; Khazarjian A; Maulin L; Alfandari S; Caillaux M; Dubreuil L; Mouton Y
    J Antimicrob Chemother; 2001 Dec; 48(6):927-30. PubMed ID: 11733482
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 3():S513-7. PubMed ID: 3931199
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections.
    Lipsky BA; Tack KJ; Kuo CC; Wang SP; Grayston JT
    Am J Med; 1990 Dec; 89(6):722-4. PubMed ID: 2252040
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ciprofloxacin in severe infections.
    Aswapokee N; Pruksachatvuthi S; Aswapokee P
    J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Ten-year experience with the use of ofloxacin in the treatment of wound infection].
    Blatun LA; Iakovlev VP; Svetukhin AM; Puchkova LS; Izotova GN
    Antibiot Khimioter; 1996; 41(9):73-6. PubMed ID: 9005792
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Soft tissue infections in the emergency department: the case for the use of 'simple' antibiotics.
    Powers RD
    South Med J; 1991 Nov; 84(11):1313-5. PubMed ID: 1948213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):141-4. PubMed ID: 1572139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.